Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Shareholders' Equity

v3.23.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Ordinary shares
Additional paid-in capital
Accumulated other comprehensive Income
Accumulated deficit
Total
Balance at Dec. 31, 2019 $ 111,626 $ 1,127 $ (110,311) $ 2,442
Balance (in Shares) at Dec. 31, 2019 120,652,683        
Deemed dividends related to the warrants exercise 715 (715)
Issuance of share capital and warrants, net of issuance expenses 17,683 17,683
Issuance of share capital and warrants, net of issuance expenses (in Shares) 341,766,780        
Issuance of share capital 75 75
Issuance of share capital (in Shares) 1,350,000        
Share-based payments 317 317
Net loss (14,443) (14,443)
Balance at Dec. 31, 2020 130,416 1,127 (125,469) 6,074
Balance (in Shares) at Dec. 31, 2020 463,769,463        
Issuance of share capital due to warrants exercise, net of issuance expenses of $ 980 (Note 10b(9), 10b(11) and 10b(12))   11,767 11,767
Issuance of share capital due to warrants exercise, net of issuance expenses of $ 980 (Note 10b(9), 10b(11) and 10b(12)) (in Shares) 293,926,830        
Issuance of share capital in exchange for services 68 68
Issuance of share capital in exchange for services (in Shares) 1,050,000        
dividends related to the warrants exercise 2,590 (2,590)
Issuance of share capital and warrants, net of issuance expenses   8,690   8,690
Issuance of share capital and warrants, net of issuance expenses (in Shares) 57,000,000        
Share-based payments 398 398
Net loss (12,615) (12,615)
Balance at Dec. 31, 2021 153,929 1,127 (140,674) 14,382
Balance (in Shares) at Dec. 31, 2021 815,746,293        
Share-based payments 263 263
Net loss (10,173) (10,173)
Balance at Dec. 31, 2022 $ 154,192 $ 1,127 $ (150,847) $ 4,472
Balance (in Shares) at Dec. 31, 2022 815,746,293